Meadow Creek Investment Management’s Health Catalyst HCAT Stock Holding History

Meadow Creek Investment Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.26M	Buy	+39,814	New	+$1.57M	0.02%	425

Other funds holding HCAT

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Meadow Creek Investment Management's HCAT Position: Q3 2019 in Review

Meadow Creek Investment Management opened a new position in Health Catalyst (HCAT) in Q3 2019: 39,814 shares worth $1.26M. The stake represents 0.02% of the portfolio and ranks #425 among its holdings.

86 funds tracked by Wall St. Rank hold HCAT as of Q3 2019.

Meadow Creek Investment Management held 39,814 shares of Health Catalyst worth $1.26M as of Q3 2019.
Health Catalyst was a new Meadow Creek Investment Management position in Q3 2019.
Health Catalyst made up 0.02% of Meadow Creek Investment Management's portfolio in Q3 2019, its #425 holding.
86 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.